Archives
-
Lysis Buffer for Reliable Mouse Genotyping
2026-08-28
Improve mouse genotyping workflows with a lysis buffer designed for rapid tissue digestion and PCR-ready genomic DNA release. This practical guide covers workflow setup, assay decisions, optimization parameters, and troubleshooting for tail, toe, and ear samples.
-
Viral RIPK3 Degradation Drives Inflammation
2026-08-28
Liu and colleagues identified a conserved orthopoxvirus factor, vIRD, that recruits SCF ubiquitin-ligase machinery to drive proteasomal degradation of RIPK3. The study shows that this apparently anti-necroptotic mechanism can increase viral replication and inflammatory disease in vivo, providing a mechanistic link between pathogen evolution, host-cell death, and poxvirus virulence.
-
AmpliFold Capture-and-Release for LFA Sensitivity
2026-08-27
The ChemRxiv preprint introduces AmpliFold, a capture-and-release architecture that uses triggered release and high-affinity rebinding to reduce the kinetic burden on lateral flow assay test lines. In a HER2 model, linker and receptor-density optimization produced up to 16-fold lower detection limits and a 12-fold sensitivity improvement with large gold nanoparticles, while also highlighting important translation constraints.
-
Pronase E for Ferroptosis Protein Preparation
2026-08-27
Pronase E provides broad, high-activity proteolysis for reproducible protein digestion, peptide mapping, and proteomics-oriented sample preparation. This guide translates the CUL3–MTDH ferroptosis findings in triple-negative breast cancer into practical assay workflows while clearly separating evidence from optimization recommendations.
-
Protease Inhibitor Cocktail for MS Proteomics
2026-08-26
Discover how a Protease Inhibitor Cocktail can improve protein degradation prevention in MS-oriented extraction workflows. This guide connects inhibitor selection with CYR61–migrasome research and practical assay-control decisions.
-
Targeting Mitocytosis to Enhance Mitochondrial Therapy
2026-08-26
Deng and colleagues show that mitocytosis can weaken mitochondria-targeted antimetastatic therapy in migrasome-rich breast tumors. Their hybrid membrane nanoplatform combines mitochondrial damage with integrin-mediated mitocytosis inhibition, substantially improving treatment activity in the 4T1 model.
-
Cell lysis buffer for WB and IP: CAF Assays
2026-08-25
Build cleaner Western blot, co-IP, and signaling workflows around a non-denaturing extraction system designed to preserve both proteins and labile interactions. This guide translates the CAF–ANGPTL4–IQGAP1 prostate cancer study into practical sample-handling, assay-selection, and troubleshooting decisions.
-
PPACK Dihydrochloride in Thrombin Assays
2026-08-25
PPACK Dihydrochloride provides an irreversible thrombin clamp for separating coagulation-driven effects from receptor-specific platelet signaling. This guide translates its high-affinity chemistry into practical assay workflows, controls, and troubleshooting strategies for reproducible blood coagulation research.
-
PMSF for Reliable Protein Extraction
2026-08-24
Learn how to use PMSF as a focused serine protease safeguard for tissue, cell, and Western blot lysates. The workflow also shows how better sample preservation can strengthen ferroptosis and cardiomyopathy studies without confusing a sample-preparation reagent with a live-cell mechanism.
-
Pronase E for Ferroptosis Proteomics
2026-08-24
Discover how Pronase E (Activity ≥ 7000 U/g) can strengthen exploratory protein digestion, limited-proteolysis, and peptide-mapping workflows related to ferroptosis research. This practical guide distinguishes sample-preparation utility from mechanistic proof in CUL3–MTDH studies.
-
Phosphatase Inhibitor Cocktail for Signaling Assays
2026-08-23
Protect transient serine/threonine and tyrosine phosphorylation during lysis, immunoblotting, kinase assays, and mass spectrometry. The dual-tube format separates solvent systems and inhibitor coverage, making sequential addition a practical advantage for signaling workflows that demand reproducibility.
-
Novobiocin Sodium: From Gyrase to Translation
2026-08-22
Novobiocin Sodium is more than a conventional antibacterial tool: it is a controllable perturbagen for connecting DNA replication stress with cellular phenotypes and exploratory antiparasitic biology. This thought-leadership analysis examines its mechanism, assay strategy, translational boundaries, and potential role in DNA damage, apoptosis, metabolic enzyme protease, and antibiotic resistance research.
-
SDUY104 and Compensatory PI3K-AKT Signaling in PDAC
2026-08-22
This study develops the furanyl amide-based SHP2 allosteric inhibitor SDUY104 and shows that its activity in KRAS-driven pancreatic cancer is limited by compensatory PI3K-AKT signaling. The work provides a mechanistic rationale for combining SHP2 inhibition with ERK or PI3K blockade, with the SDUY104–BKM-120 combination showing improved activity in a PANC-1 xenograft model.
-
Inducing Right Ventricular-Like Cardiomyocytes from hPSCs
2026-08-21
Saito et al. developed a modified GiWi differentiation strategy that enriches second heart field-like progenitors and generates right ventricular-like cardiomyocytes from human pluripotent stem cells. The resulting cells differed from left ventricular-like controls in chamber-associated gene expression, spontaneous contraction, calcium handling, and cell size, providing a useful framework for chamber-specific disease modeling.
-
Bestatin and Actinonin: Evidence for Intracellular Action
2026-08-20
The reference study shows that bestatin and actinonin suppress proliferation in U937 and K562 cells primarily through intracellular activity rather than inhibition of cell-surface aminopeptidases alone. Efflux-modifier experiments further identify MRP and P-glycoprotein as important determinants of inhibitor accumulation, providing a mechanistic framework for interpreting transporter-sensitive antiproliferative assays.